Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2703-2707

  Pascual, M J ^a   Macias, R I R ^a   Garcia Del Pozo, J ^a   Serrano, M A ^a   Marin, J J G ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile acid; Cancer; Liver; Pregnancy; Targeting and tumour

Indexed keywords

BAMET R2; BILE ACID; CISPLATIN; CYTOSTATIC AGENT; DIAMMINECHLOROCHOLYLGLYCINATE PLATINUM; GLYCOCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD PLACENTA BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG STRUCTURE; DRUG TISSUE LEVEL; FEMALE; GESTATIONAL AGE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; TOXICITY; TROPHOBLAST;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; FETUS; MATERNAL-FETAL EXCHANGE; ORGANOPLATINUM COMPOUNDS; PLACENTA; PREGNANCY; RATS; TISSUE DISTRIBUTION; URSODEOXYCHOLIC ACID;

EID: 0035152983     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Diagnosis and treatment. Drugs five years later. Cisplatin
2. Clinical pharmacokinetics of cytostatic drugs: Efficacy and toxicity
3. Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine treatment
4. Overcoming of cisplatin-resistance by a free and liposome-encapsulated bile acid derivative, Bamet-R 2
5. Antitumor activity of platinum analogs
6. Gynaecologic tumours
7. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
8. Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure
9. DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R 2
10. Transport and biotransformation of the new cytostatic complex cisdiammineplatinun(II)- chlorocholylglycinate (Bamet-R2) by the rat liver
11. Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2)
12. Further evidence for the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors
13. Carriers involved in the targeting of cytostatic bile acid-cisplatin derivatives toward liver cells
14. Relationship between bile acid transplacental gradients and transport across the fetal-facing plasma membrane of the human trophoblast
15. Effect of maternal cholestasis on bile acid transfer across the placenta-maternal liver tandem
16. Bile acid transport by basal membrane vesicles of human term placental trophoblast
17. Bicarbonate-induced activation of taurocholate transport across the basal plasma membrane of the human term trophoblast
18. ATP-dependent bile acid transport across the microvillous membrane of human term trophoblast
19. Synthesis and characterization of the new cytostatic complex cis-diammineplatinum(II) chlorocholylglycinate. Cytostatic activity
20. Efficiency of Bamet-R2 treatment on orthotopically implanted Hepa 1-6 liver tumors in nude mice
21. Identification of bile salt transporters in rat and human placenta
22. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile
23. Biliary secretion and excretion. The hepatobiliary component of the enterohepatic circulation of bile acids
24. Expression of multidrug resistance associated proteins in human term placenta
25. Metal complexes for therapy and diagnosis of drug resistence